| | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
---|
|
décembre 2021 - 60 Spécialités |
|
| | IPro | IPat | V/S | Comirnaty® 30 Mikrogramm/Dosis | 10 | DDP | DDP | N.O. | | | Pfizer AG | B | FB | | G |  |
| | IPro | IPat | V/S | Comirnaty 3 Mikrogramm/Dosis Konzentrat zur Herstellung einer Injektionsdispersion | 10 | DDP | DDP | N.O. | | Tozinameranum 3 µg | Pfizer AG | B | FB | | G |  |
| | IPro | | | Takrozem 0,3 mg/g | 10 g | DDP | DDP | N.O. | | Onguent: Tacrolimusum | Pierre Fabre Pharma SA | B | FB | | G |  |
| | IPro | | | Takrozem 0,3 mg/g | 30 g | DDP | DDP | N.O. | | Onguent: Tacrolimusum | Pierre Fabre Pharma SA | B | FB | | G |  |
| | IPro | | | Takrozem 0,3 mg/g | 60 g | DDP | DDP | N.O. | | Onguent: Tacrolimusum | Pierre Fabre Pharma SA | B | FB | | G |  |
| | IPro | | | Ibu Zentiva 400 mg | 20 | 1.48 | 10.85 | 10% | | Comprimés filmés: Ibuprofenum 400 mg | Helvepharm AG | B / LS / SG | FB | | G |  |
| | IPro | | | Ibu Zentiva 400 mg | 50 | 3.37 | 12.90 | 10% | | Comprimés filmés: Ibuprofenum 400 mg | Helvepharm AG | B / LS / SG | FB | | G |  |
| | IPro | | | Ibu Zentiva 600 mg | 20 | 2.16 | 11.60 | 10% | | Comprimés filmés: Ibuprofenum 600 mg | Helvepharm AG | B / LS / SG | FB | | G |  |
| | IPro | | | Ibu Zentiva 600 mg | 100 | 8.63 | 25.85 | 10% | | Comprimés filmés: Ibuprofenum 600 mg | Helvepharm AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Quetiapin Spirig HC 25 | 60 | 16.85 | 34.75 | 10% | | Comprimés filmés: Quetiapinum 25 mg | Spirig HealthCare AG | ● B / LS / SG | FB | | G |  |
| | IPro | | | Quetiapin Spirig HC 100 | 60 | 40.54 | 60.55 | 10% | | Comprimés filmés: Quetiapinum 100 mg | Spirig HealthCare AG | B / LS / SG | FB | | G |  |
| | IPro | | | Quetiapin Spirig HC 100 | 100 | 66.50 | 88.75 | 10% | | Comprimés filmés: Quetiapinum 100 mg | Spirig HealthCare AG | B / LS / SG | FB | | G |  |
| | IPro | | | Quetiapin Spirig HC 200 | 60 | 83.32 | 107.05 | 10% | | Comprimés filmés: Quetiapinum 200 mg | Spirig HealthCare AG | B / LS / SG | FB | | G |  |
| | IPro | | | Quetiapin Spirig HC 200 | 100 | 136.78 | 165.15 | 10% | | Comprimés filmés: Quetiapinum 200 mg | Spirig HealthCare AG | ● B / LS / SG | FB | | G |  |
| | IPro | | | Quetiapin Spirig HC 300 | 60 | 117.74 | 144.50 | 10% | | Comprimés filmés: Quetiapinum 300 mg | Spirig HealthCare AG | B / LS / SG | FB | | G |  |
| | IPro | | | Quetiapin Spirig HC 300 | 100 | 193.06 | 226.40 | 10% | | Comprimés filmés: Quetiapinum 300 mg | Spirig HealthCare AG | B / LS / SG | FB | | G |  |
L | | IPro | IPat | | Sitagliptin Sandoz eco 25 mg | 28 | 14.08 | 31.75 | 10% | | Comprimés filmés: Sitagliptinum 25 mg | Sandoz Pharmaceuticals AG | B / LS / SG | FB | | G |  |
L | | IPro | IPat | | Sitagliptin Sandoz eco 25 mg | 98 | 49.25 | 70.00 | 10% | | Comprimés filmés: Sitagliptinum 25 mg | Sandoz Pharmaceuticals AG | B / LS / SG | FB | | G |  |
L | | IPro | | | Sitagliptin Sandoz eco 50 mg | 28 | 14.08 | 31.75 | 10% | | Comprimés filmés: Sitagliptinum 50 mg | Sandoz Pharmaceuticals AG | B / LS / SG | FB | | G |  |
L | | IPro | | | Sitagliptin Sandoz eco 50 mg | 98 | 49.25 | 70.00 | 10% | | Comprimés filmés: Sitagliptinum 50 mg | Sandoz Pharmaceuticals AG | ● B / LS / SG | FB | | G |  |
L | | IPro | | | Sitagliptin Sandoz eco 100 mg | 28 | 14.08 | 31.75 | 10% | | Comprimés filmés: Sitagliptinum 100 mg | Sandoz Pharmaceuticals AG | ● B / LS / SG | FB | | G |  |
L | | IPro | | | Sitagliptin Sandoz eco 100 mg | 98 | 49.25 | 70.00 | 10% | | Comprimés filmés: Sitagliptinum 100 mg | Sandoz Pharmaceuticals AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | CM | Pantoprazol Viatris 20 mg | 15 | 3.71 | 13.30 | 10% | | Comprimés résistants au suc gastrique: Pantoprazolum 20 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G |  |
| | IPro | IPat | CM | Pantoprazol Viatris 20 mg | 30 | 6.44 | 23.50 | 10% | | Comprimés résistants au suc gastrique: Pantoprazolum 20 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G |  |
| | IPro | IPat | CM | Pantoprazol Viatris 20 mg | 60 | 11.99 | 29.60 | 10% | | Comprimés résistants au suc gastrique: Pantoprazolum 20 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G |  |
| | IPro | IPat | CM | Pantoprazol Viatris 20 mg | 120 | 21.92 | 40.50 | 10% | | Comprimés résistants au suc gastrique: Pantoprazolum 20 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G |  |
| | IPro | | CM | Pantoprazol Viatris 40 mg | 7 | 3.15 | 12.70 | 10% | | Comprimés résistants au suc gastrique: Pantoprazolum 40 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G |  |
| | IPro | | CM | Pantoprazol Viatris 40 mg | 15 | 5.92 | 15.75 | 10% | | Comprimés résistants au suc gastrique: Pantoprazolum 40 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G |  |
| | IPro | | CM | Pantoprazol Viatris 40 mg | 30 | 11.06 | 28.60 | 10% | | Comprimés résistants au suc gastrique: Pantoprazolum 40 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G |  |
| | IPro | | CM | Pantoprazol Viatris 40 mg | 60 | 15.44 | 33.50 | 10% | | Comprimés résistants au suc gastrique: Pantoprazolum 40 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G |  |
| | IPro | | CM | Pantoprazol Viatris 40 mg | 105 | 27.14 | 46.30 | 10% | | Comprimés résistants au suc gastrique: Pantoprazolum 40 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg) | 100 | 5.94 | 15.70 | 10% | | Comprimés: 2 Principes actifs | Devatis AG | B / LS / SG | FB | | G |  |
| | IPro | | | Levodopa / Benserazid Devatis 125 mg (100 mg + 25 mg) | 30 | 3.55 | 13.10 | 10% | | Comprimés: 2 Principes actifs | Devatis AG | B / LS / SG | FB | | G |  |
| | IPro | | | Levodopa / Benserazid Devatis 125 mg (100 mg + 25 mg) | 100 | 10.01 | 27.30 | 10% | | Comprimés: 2 Principes actifs | Devatis AG | B / LS / SG | FB | | G |  |
| | IPro | | | Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg) | 30 | 6.13 | 15.90 | 10% | | Comprimés: 2 Principes actifs | Devatis AG | B / LS / SG | FB | | G |  |
| | IPro | | | Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg) | 100 | 18.65 | 36.70 | 10% | | Comprimés: 2 Principes actifs | Devatis AG | B / LS / SG | FB | | G |  |
L | | IPro | IPat | | Sapropterin Dipharma 100 mg | 30 | 808.62 | 897.15 | 10% | | polvere per soluzione orale: Sapropterini Dihydrochloridum 100 mg | Dipharma SA | B / LS / SG | FB | | G |  |
L | | IPro | | | Sapropterin Dipharma 500 mg | 30 | 2979.15 | 3256.40 | 10% | | polvere per soluzione orale: Sapropterini Dihydrochloridum 500 mg | Dipharma SA | B / LS / SG | FB | | G |  |
L | | IPro | IPat | | Wilentin 250 mg | 100 | 2314.55 | 2533.65 | 10% | | Capsules: Trientini Dihydrochloridum 250 mg | Future Health Pharma GmbH | B / LS | FB | | G |  |
| | IPro | IPat | V/S | Comirnaty® 30 Mikrogramm/Dosis | 10 | DDP | DDP | N.O. | | | Pfizer AG | B | FB | | G |  |
| | IPro | IPat | V/S | Comirnaty® 10 Mikrogramm/Dosis | 10 | DDP | DDP | N.O. | | | Pfizer AG | B | FB | | G |  |
| | IPro | IPat | V/S | Comirnaty® 30 Mikrogramm/Dosis | 195 | DDP | DDP | N.O. | | | Pfizer AG | B | FB | | G |  |
| | IPro | IPat | V/S | Comirnaty® 10 Mikrogramm/Dosis | 195 | DDP | DDP | N.O. | | | Pfizer AG | B | FB | | G |  |
| | IPro | IPat | | Oxlumo 94.5 mg / 0.5 ml | | DDP | DDP | N.O. | | | Alnylam Switzerland GmbH | B | FB | | G |  |
| | IPro | | | Ibuprofen Fresenius i.v. 400 mg / 100 ml | 10 x 100 ml | DDP | DDP | N.O. | | Solution pour perfusion: Ibuprofenum 4 mg | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |
| | IPro | | | Ibuprofen Fresenius i.v. 400 mg / 100 ml | 40 x 100 ml | DDP | DDP | N.O. | | Solution pour perfusion: Ibuprofenum 4 mg | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |
| | IPro | | | Alluzience | | DDP | DDP | N.O. | | | Future Health Pharma GmbH | A | FB | | G |  |
| | IPro | | | Alluzience | 2 | DDP | DDP | N.O. | | | Future Health Pharma GmbH | A | FB | | G |  |
| | IPro | | | Midazolam Accord 5 mg/5 ml | 5 ml | DDP | DDP | N.O. | | Solution injectable en seringue prête à l'emploi: Midazolamum 5mg / 5ml | Accord Healthcare AG | B | FB | | G |  |
| | IPro | IPat | | Takrozem 1 mg/g | 10 g | DDP | DDP | N.O. | | Onguent: Tacrolimusum 1 mg | Pierre Fabre Pharma SA | B | FB | | G |  |
| | IPro | IPat | | Takrozem 1 mg/g | 30 g | 23.25 | 41.70 | N.O. | | Onguent: Tacrolimusum 1 mg | Pierre Fabre Pharma SA | B | FB | | G |  |
| | IPro | IPat | | Takrozem 1 mg/g | 60 g | 40.92 | 60.90 | N.O. | | Onguent: Tacrolimusum 1 mg | Pierre Fabre Pharma SA | B | FB | | G |  |
| | IPro | IPat | | Ibu Zentiva 200 mg | 30 | DDP | DDP | N.O. | | Comprimés filmés: Ibuprofenum 200 mg | Helvepharm AG | B | FB | | G |  |
| | IPro | IPat | | Ibu Zentiva 200 mg | 100 | DDP | DDP | N.O. | | Comprimés filmés: Ibuprofenum 200 mg | Helvepharm AG | B | FB | | G |  |
| | | IPat | H | Similasan Reisekrankheit | 4.5 g | DDP | DDP | N.O. | | Globules: 4 Principes actifs | Similasan AG | D | FB | | G |  |
| | | IPat | H | Similasan Reisekrankheit | 15 g | DDP | DDP | N.O. | | Globules: 4 Principes actifs | Similasan AG | D | FB | | G |  |
| | IPro | | | Wilentin 300 mg | 100 | DDP | DDP | N.O. | | Capsules: Trientini Dihydrochloridum 300 mg | Future Health Pharma GmbH | B | FB | | G |  |
| | IPro | IPat | | Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg) | 30 | 1.78 | 6.65 | N.O. | | Comprimés: 2 Principes actifs | Devatis AG | B | FB | | G |  |
| | | IPat | | Gemmo Gelenkbeschwerden | 30 ml | DDP | DDP | N.O. | | Spray zur Anwendung in der Mundhöhle: 3 Principes actifs | Spagyros AG | D | FB | | G |  |
| | IPro | | | Heparin Sintetica 20`000 UI/48 ml | | DDP | DDP | N.O. | | soluzione per infusione: Heparinum Natricum 417 UI/ml | Sintetica SA | B | FB | | G |  |